Mizuho initiated coverage of Patterson Companies (PDCO) with a Neutral rating and $23 price target. The stock valuation is currently below its historical averages, but the company’s current FY25 EPS guidance may be too challenging to achieve, leading to potential downward revisions to the current outlook and Street estimates, the analyst tells investors in a research note. Patterson is facing company-specific risk related to the potential non-renewal of its long-term distribution contract with Dentsply Sirona (XRAY) or risk of renewal at less favorable financial terms, while the firm’s dental survey also suggests minimal improvement in the challenging U.S. dental sector outlook for 2025 vs. 2024, Mizuho adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDCO:
- Patterson Companies price target trimmed to $28 at Leerink ahead of earnings
- PDCO Upcoming Earnings Report: What to Expect?
- Patterson Dental Supply extends strategic relationship with PDS Health
- Ex-Dividend Date Nearing for These 10 Stocks – Week of October 14, 2024
- Patterson Companies price target lowered to $22 from $23 at Evercore ISI